Evidence map›Paper›PMID 42525238›Full record

ArticleEuropean child & adolescent psychiatry2026

VigiBase suggests that the number of deaths by suicide in adolescents with schizophrenia as a result of not taking clozapine may be much higher than the number of deaths from agranulocytosis after taking clozapine.

Sara Jiménez-Fernández, Carlos De Las Cuevas, Emilio J Sanz, Carmen Moreno, Celso Arango, Jose de Leon

Abstract readLetter
PubMed Publisher
In one paragraph

Article in European child & adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sara Jiménez-FernándezDepartment of Psychiatry, School of Medicine, Instituto Universitario de Neurociencias Federico Olóriz, University of Granada, Granada, Spain. sjimenez@ugr.es.ORCID http://orcid.org/0000-0003-1515-2413
Carlos De Las CuevasDepartment of Internal Medicine, Dermatology and Psychiatry, School of Medicine, Instituto Universitario de Neurociencia (IUNE), University of La Laguna, Canary Islands, Spain.ORCID http://orcid.org/0000-0001-5742-905X
Emilio J SanzDepartment of Physical Medicine and Pharmacology, School of Medicine, Universidad de La Laguna, Canary Islands, Spain.ORCID http://orcid.org/0000-0001-6788-4435
Carmen MorenoSchool of Medicine, Hospital Universitario La Paz, Universidad Autónoma de Madrid, CIBERSAM, IdiPAZ, Madrid, Spain.ORCID http://orcid.org/0000-0003-0541-4846
Celso ArangoSchool of Medicine, Hospital Universitario La Paz, Universidad Autónoma de Madrid, CIBERSAM, IdiPAZ, Madrid, Spain.ORCID http://orcid.org/0000-0003-3382-4754
Jose de LeonMental Health Research Center at Eastern State Hospital, Lexington, KY, USA.ORCID http://orcid.org/0000-0002-7756-2314

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clozapine/adverse effectsClozapine/therapeutic useClozapine/toxicityMortality/drug effectsSuicide, attemptedSuicide, completed

Identifiers

PMID42525238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.